Coupang Director Sells $14.44M in Stock Amid Growth by Mark Eisenberg 18.06.2024 "Coupang Director Benjamin Sun sells $14.44M in stock, signaling optimism despite challenges. Q1 2024 shows 33% revenue rise, boosting investor ...
Aerovate Therapeutics Stock Downgraded After Trial Setback by Mark Eisenberg 17.06.2024 Aerovate Therapeutics stock downgraded by BTIG after AV-101 trial setback; mixed analyst views and future pivotal readouts crucial for investors.
Bitcoin Plunges: Saylor’s Advice to Holders Amid Volatility by John Darbie 17.06.2024 Bitcoin dips below $66K. Michael Saylor of MicroStrategy advises focus on crypto fundamentals, advocates buying the dip amid market volatility.
Shenzhen Microgate’s Shrinking Dividend, But Growth Potential by Mark Eisenberg 16.06.2024 This dividend stock, growing distributions at 21% p.a. since 2014, shows solid potential despite a current yield of 1.2%, below ...
Investor Optimism High, but Growth Lacking for ideaForge? by Mark Eisenberg 15.06.2024 ideaForge Technology saw a 28% earnings surge last year. Explore the potential and risks, plus other high-growth firms with low ...
Top Wall Street Analysts Recommend 3 Dividend Stocks by Mark Eisenberg 25.04.2024 Scotto, Biggar, and Liani rank among top analysts with profitable ratings & impressive average returns, according to TipRanks data. Cisco ...
Enbridge: Top High-Yield Dividend Stock by Mark Eisenberg 25.04.2024 Enbridge aims to pay out 60-70% of its cash flow in dividends while retaining the rest for new investments. A ...
Top Energy Stocks to Buy: ExxonMobil vs. Chevron by Terry Bingman 25.04.2024 ExxonMobil and Chevron are ideal energy investment options, despite the recent market drop in demand for oil and natural gas. ...
3 Reasons to Buy EPD Stock Now by Terry Bingman 21.04.2024 Enterprise Products Partners is an attractive stock with a strong track record and consistent distribution growth. With a low trading ...
Medical Properties Trust Soaring Despite Challenges by Mark Eisenberg 19.04.2024 Medical Properties Trust owns 25% of the joint venture, but investors should avoid the stock for now. The Motley Fool ...